Orange Book product · Brand (NDA)
LOPURIN
ALLOPURINOL
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
ALLOPURINOL
Strength
100MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 018297
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1984ALLOPURINOLBrand (NDA)
NDA 018241 · WATSON LABS
- 1984ALLOPURINOLBrand (NDA)
NDA 018785 · WATSON LABS
- 1984ALLOPURINOLBrand (NDA)
NDA 018832 · WATSON LABS
- 1984ALLOPURINOLBrand (NDA)
NDA 018877 · WATSON LABS
- —ZYLOPRIMBrand (NDA)
NDA 016084 · CASPER PHARMA LLC
- 2025ALLOPURINOLGeneric (ANDA)
ANDA 215091 · AUROBINDO PHARMA LTD
- 2023ALLOPURINOLGeneric (ANDA)
ANDA 211807 · LUPIN
- 2023ALLOPURINOLGeneric (ANDA)
ANDA 217748 · HETERO LABS LTD V
- 2022ALLOPURINOLGeneric (ANDA)
ANDA 214443 · HARMAN FINOCHEM
- 2019ALLOPURINOLGeneric (ANDA)
ANDA 211820 · UNICHEM
- 2017ALLOPURINOLGeneric (ANDA)
ANDA 210117 · ZYDUS PHARMS
- 2016ALLOPURINOLGeneric (ANDA)
ANDA 204467 · REGCON HOLDINGS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
